US venture capital invests $7.5m in Israeli water technology

Originally developed by Elif Environmental in Ariel in the 1990s, Aquarius has acquired the global license to market the patented sludge-free wastewater treatment technology in North America, Israel and Spain.

By SHARON WROBEL
September 12, 2006 08:39
1 minute read.

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

L Capital Partners, the Manhattan based venture capital fund founded by global investor Jonathan Leitersdorf, has invested $7.5 million in Aquarius, an Israeli technology company, in an effort to globally market the water company's sludge-free patented solutions to wastewater management. "The main problem and cost issue with wastewater management is treating sludge," said Oded Weiss, CFO of L Capital Partners. "We see major potential for marketing this unique technology, particularly in North America." Originally developed by Elif Environmental in Ariel in the 1990s, Aquarius has acquired the global license to market the patented sludge-free wastewater treatment technology in North America, Israel and Spain. Instead of treating or simply reducing sludge, Aquarius Technologies' solutions prevent it by eliminating both biodegradable and nonbiodegradable pollutants. Using Aquarius's patented multistage activated biological process, no sludge is created in the second stage. As a result, the need for the traditional third, or tertiary, stage of wastewater treatment is eliminated. Instead, wastewater is aerated and then processed through a series of chambers containing ever-larger microorganisms, or bugs. The smallest bugs eat the pollutants and then larger bugs eat the smaller bugs as they move from one chamber to the next. The chemical-free "microbial food chain process" prevents the creation of sludge. L Capital Partners, with $165m. under management, was established in September 2004. Its partners include the US Small Business Administration and Bank Leumi. The cooperation of L Capital Partners with the American SBA (Small Business Association), which leverages money raised, is expected to open to Israeli companies a unique opportunity to penetrate global markets. "We currently have 10 investments of which three are investments in Israeli companies," said Weiss.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS